573 research outputs found
TPOAb and thyroid function are not associated with breast cancer outcome: evidence from a large-scale study using data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001)
Background: Small-scale studies correlated the presence of thyroid autoimmunity with both improved or worsened breast cancer outcome. Objectives: We aimed to clarify this association in a large cohort using the phase III, randomized, controlled Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001). Methods: TACT women >18 years old with node-positive or high-risk node-negative early breast cancer (pT1â3a, pN0â1, M0), with stored plasma (n = 1,974), taken 15.5 (median; IQR 7.0â24.0) months after breast surgery were studied. Patients had also received chemotherapy (100%), radiotherapy (1,745/1,974; 88.4%), hormonal therapy (1,378/ 1,974; 69.8%), or trastuzumab (48/1,974; 2.4%). History of thyroid diseases and/or related treatments was not available. The prognostic significance of autoantibodies to thyroid peroxidase (TPOAb; positive â„6 kIU/L), free-thyroxine and thyrotropin (combined: euthyroid, hypothyroid, hyperthyroid) was evaluated for disease-free survival (DFS), overall-survival (OS), and time-to-recurrence (TTR), with Cox regression models in univariate and multivariable analyses. The extended median follow-up was 97.5 months. Results: No difference in DFS was found by TPOAb status (unadjusted hazard ratio [HR]: 0.97, 95%CI: 0.78â1.19; p = 0.75) and/or thyroid function (unadjusted HR [hypothyroid vs. euthyroid]: 1.15, 95% CI: 0.79â1.68; p = 0.46; unadjusted HR [hyperthyroid vs. euthyroid]: 1.14, 95% CI: 0.82â1.61; p = 0.44). Similar results were obtained for OS, TTR, multivariable analyses, when TPOAb titre by tertiles was considered, and in a subgroup of 123 patients with plasma collected before adjuvant treatments. Conclusions: No evidence for a prognostic role of TPOAb and/or thyroid function in moderate-to-high-risk early breast cancer was found in the largest and longest observational study to date
Clinical response to antibiotic regimens in lower limb cellulitis: a systematic review
There is variation in the treatment of lower limb cellulitis (LLC) with no agreement on the most effective antibiotic regimen. Many patients with cellulitis fail to respond to first-line antibiotics. This can negatively affect patient care and result in unnecessary hospital admissions. The aim of this systematic review was to determine the clinical response and safety of antibiotic regimens for the management of LLC. A systematic review for randomized controlled trials (RCTs) was conducted using OVID MEDLINE, Ovid Embase and Cochrane Central Register of Controlled Trials in January 2019. Outcomes of interest included the clinical response to antibiotic regimens (type, dose, route, duration) and the safety of antibiotics in LLC. Trial quality was identified using the Cochrane Risk of Bias tool. Four RCTs were included. All included studies showed no significant differences between the clinical response to different antibiotic type, administration route, treatment duration or dose. LLC may be overtreated and shorter courses of oral antibiotics, possibly with lower doses, may be more suitable. There is a lack of published data on the clinical response and safety of antibiotics in LLC. Three studies were high risk for bias overall. Further high-quality studies may help determine whether less intensive antibiotic regimens can effectively treat LLC
Probing elastic and inelastic breakup contributions to intermediate-energy two-proton removal reactions
The two-proton removal reaction from 28Mg projectiles has been studied at 93
MeV/u at the NSCL. First coincidence measurements of the heavy 26Ne projectile
residues, the removed protons and other light charged particles enabled the
relative cross sections from each of the three possible elastic and inelastic
proton removal mechanisms to be determined. These more final-state-exclusive
measurements are key for further interrogation of these reaction mechanisms and
use of the reaction channel for quantitative spectroscopy of very neutron-rich
nuclei. The relative and absolute yields of the three contributing mechanisms
are compared to reaction model expectations - based on the use of eikonal
dynamics and sd-shell-model structure amplitudes.Comment: Accepted for publication in Physical Review C (Rapid Communication
Elastic breakup cross sections of well-bound nucleons
The 9Be(28Mg,27Na) one-proton removal reaction with a large proton separation
energy of Sp(28Mg)=16.79 MeV is studied at intermediate beam energy.
Coincidences of the bound 27Na residues with protons and other light charged
particles are measured. These data are analyzed to determine the percentage
contributions to the proton removal cross section from the elastic and
inelastic nucleon removal mechanisms. These deduced contributions are compared
with the eikonal reaction model predictions and with the previously measured
data for reactions involving the re- moval of more weakly-bound protons from
lighter nuclei. The role of transitions of the proton between different bound
single-particle configurations upon the elastic breakup cross section is also
quantified in this well-bound case. The measured and calculated elastic breakup
fractions are found to be in good agreement.Comment: Phys. Rev. C 2014 (accepted
Correlations in intermediate-energy two-proton removal reactions
We report final-state-exclusive measurements of the light charged fragments
in coincidence with 26Ne residual nuclei following the direct two-proton
removal from a neutron-rich 28Mg secondary beam. A Dalitz-plot analysis and
comparisons with simulations show that a majority of the triple- coincidence
events with two protons display phase-space correlations consistent with the
(two-body) kinematics of a spatially-correlated pair-removal mechanism. The
fraction of such correlated events, 56(12) %, is consistent with the fraction
of the calculated cross section, 64 %, arising from spin S = 0 two-proton
configurations in the entrance-channel (shell-model) 28Mg ground state wave
function. This result promises access to an additional and more specific probe
of the spin and spatial correlations of valence nucleon pairs in exotic nuclei
produced as fast secondary beams.Comment: accepted for publication in Physical Review Letter
An Exploratory Study into the Factors Impeding Ethical Consumption
Although consumers are increasingly engaged with ethical factors when forming opinions about products and making purchase decisions, recent studies have highlighted significant differences between consumersâ intentions to consume ethically, and their actual purchase behaviour. This article contributes to an understanding of this âethical purchasing gapâ through a review of existing literature, and the inductive analysis of focus group discussions. A model is suggested which includes exogenous variables such as moral maturity and age which have been well covered in the literature, together with further impeding factors identified from the focus group discussions. For some consumers, inertia in purchasing behaviour was such that the decision-making process was devoid of ethical considerations. Several manifested their ethical views through post-purchase dissonance and retrospective feelings of guilt. Others displayed a reluctance to consume ethically due to personal constraints, a perceived negative impact on image or quality, or an outright negation of responsibility. Those who expressed a desire to consume ethically often seemed deterred by cynicism, which caused them to question the impact they, as an individual, could achieve. These findings enhance the understanding of ethical consumption decisions and provide a platform for future research in this area
Crowding Promotes the Switch from Hairpin to Pseudoknot Conformation in Human Telomerase RNA
Formation of a pseudoknot in the conserved RNA core domain in the
ribonucleoprotein human telomerase is required for function. In vitro
experiments show that the pseudoknot (PK) is in equilibrium with an extended
hairpin (HP) structure. We use molecular simulations of a coarse-grained model,
which reproduces most of the salient features of the experimental melting
profiles of PK and HP, to show that crowding enhances the stability of PK
relative to HP in the wild type and in a mutant associated with dyskeratosis
congenita. In monodisperse suspensions, small crowding particles increase the
stability of compact structures to a greater extent than larger crowders. If
the sizes of crowders in a binary mixture are smaller than the unfolded RNA,
the increase in melting temperature due to the two components is additive. In a
ternary mixture of crowders that are larger than the unfolded RNA, which mimics
the composition of ribosome, large enzyme complexes and proteins in E. coli,
the marginal increase in stability is entirely determined by the smallest
component. We predict that crowding can restore partially telomerase activity
in mutants, which dramatically decrease the PK stability.Comment: File "JACS_MAIN_archive_PDF_from_DOC.pdf" (PDF created from DOC)
contains the main text of the paper File JACS_SI_archive.tex + 7 figures are
the supplementary inf
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Background The optimal ways of using aromatase inhibitors or tamoxifen as endocrine treatment for early breast cancer remains uncertain. Methods We undertook meta-analyses of individual data on 31 920 postmenopausal women with oestrogen-receptor-positive early breast cancer in the randomised trials of 5 years of aromatase inhibitor versus 5 years of tamoxifen; of 5 years of aromatase inhibitor versus 2-3 years of tamoxifen then aromatase inhibitor to year 5; and of 2-3 years of tamoxifen then aromatase inhibitor to year 5 versus 5 years of tamoxifen. Primary outcomes were any recurrence of breast cancer, breast cancer mortality, death without recurrence, and all-cause mortality. Intention-to-treat log-rank analyses, stratified by age, nodal status, and trial, yielded aromatase inhibitor versus tamoxifen first-event rate ratios (RRs). Findings In the comparison of 5 years of aromatase inhibitor versus 5 years of tamoxifen, recurrence RRs favoured aromatase inhibitors significantly during years 0-1 (RR 0.64, 95% CI 0.52-0.78) and 2-4 (RR 0.80, 0.68-0.93), and non-significantly thereafter. 10-year breast cancer mortality was lower with aromatase inhibitors than tamoxifen (12.1% vs 14.2%; RR 0.85, 0.75-0.96; 2p=0.009). In the comparison of 5 years of aromatase inhibitor versus 2-3 years of tamoxifen then aromatase inhibitor to year 5, recurrence RRs favoured aromatase inhibitors significantly during years 0-1 (RR 0.74, 0.62-0.89) but not while both groups received aromatase inhibitors during years 2-4, or thereafter; overall in these trials, there were fewer recurrences with 5 years of aromatase inhibitors than with tamoxifen then aromatase inhibitors (RR 0.90, 0.81-0.99; 2p=0.045), though the breast cancer mortality reduction was not significant (RR 0.89, 0.78-1.03; 2p=0.11). In the comparison of 2-3 years of tamoxifen then aromatase inhibitor to year 5 versus 5 years of tamoxifen, recurrence RRs favoured aromatase inhibitors significantly during years 2-4 (RR 0.56, 0.46-0.67) but not subsequently, and 10-year breast cancer mortality was lower with switching to aromatase inhibitors than with remaining on tamoxifen (8.7% vs 10.1%; 2p=0.015). Aggregating all three types of comparison, recurrence RRs favoured aromatase inhibitors during periods when treatments differed (RR 0.70, 0.64-0.77), but not significantly thereafter (RR 0.93, 0.86-1.01; 2p=0.08). Breast cancer mortality was reduced both while treatments differed (RR 0.79, 0.67-0.92), and subsequently (RR 0.89, 0.81-0.99), and for all periods combined (RR 0.86, 0.80-0.94; 2p=0.0005). All-cause mortality was also reduced (RR 0.88, 0.82-0.94; 2p=0.0003). RRs differed little by age, body-mass index, stage, grade, progesterone receptor status, or HER2 status. There were fewer endometrial cancers with aromatase inhibitors than tamoxifen (10-year incidence 0.4% vs 1.2%; RR 0.33, 0.21-0.51) but more bone fractures (5-year risk 8.2% vs 5.5%; RR 1.42, 1.28-1.57); non-breast-cancer mortality was similar. Interpretation Aromatase inhibitors reduce recurrence rates by about 30% (proportionately) compared with tamoxifen while treatments diff er, but not thereafter. 5 years of an aromatase inhibitor reduces 10-year breast cancer mortality rates by about 15% compared with 5 years of tamoxifen, hence by about 40% (proportionately) compared with no endocrine treatment. Copyright (C) Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Open Access article distributed under the terms of CC BY
Rapid ascent of rhyolitic magma at Chaitén volcano, Chile
International audienceAlthough rhyolite magma has fuelled some of the Earth's largest explosive volcanic eruptions, our understanding of these events is incomplete due to the previous lack of direct observation of these eruptions. On 1 May 2008, Chaitén volcano in Chile erupted rhyolite magma unexpectedly and explosively. Here, petrological and experimental data are presented that indicate that the hydrous rhyolite magma at Chaitén ascended very rapidly from storage depth to near-surface, with velocities of the order of one metre per second
- âŠ